AMERICAN ASSOCIATION FOR CANCER RESEARCH

Lobbying for AMERICAN ASSOCIATION FOR CANCER RESEARCH

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $100,000.00 expenses · posted Oct 14, 2025

Lobbying activity 4

Budget/Appropriations

FY 2026 Appropriations for NIH, NCI, CDC, FDA, and related cancer research and prevention accounts.

Medical/Disease Research/Clinical Labs

Cancer research generally Increasing diversity in clinical trials Drug approval Pediatric cancer detection, treatment, prevention

Tobacco

Tobacco control and prevention Tobacco cessation

Health Issues

Reducing cancer disparities Cancer survivorship Preventing HPV-related cancers

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.